Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn’s disease
2013 ◽
Vol 29
(5)
◽
pp. 483-493
◽
Keyword(s):
Keyword(s):
2014 ◽
Vol 8
(5)
◽
pp. 384-391
◽
2017 ◽
Vol 23
(34)
◽
pp. 6197
◽
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 13
(7)
◽
pp. 1293-1301.e5
◽
Keyword(s):
2018 ◽
Vol 64
(1)
◽
pp. 60-67
◽
Keyword(s):